127 related articles for article (PubMed ID: 7355106)
1. [Angioimmunoblastic lymphadenopathy. Remission obtained with prednimustine after failure of corticosteroid therapy and cyclophosphamide].
Donadio D; Navarro M; Izarn P; Clot J; Emberger JM
Nouv Presse Med; 1980 Jan; 9(3):188-9. PubMed ID: 7355106
[No Abstract] [Full Text] [Related]
2. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
[No Abstract] [Full Text] [Related]
3. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
[TBL] [Abstract][Full Text] [Related]
4. Prednimustine treatment in malignant lymphomas.
Szántó I; Fleischmann T; Eckhardt S
Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
[TBL] [Abstract][Full Text] [Related]
5. [Prednimustine in treatment of acute leukemia in elderly patients].
Brandt L; Könyves I
Lakartidningen; 1977 Apr; 74(15):1490-3. PubMed ID: 321896
[No Abstract] [Full Text] [Related]
6. The antitumor effect of prednimustine in vitro and in vivo.
Hartley-Asp B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):3-7. PubMed ID: 3952519
[TBL] [Abstract][Full Text] [Related]
7. [Angioimmunoblastic lymphadenopathy treated by levamisole].
Youinou P; Andrieu JM; Herzog C
Nouv Presse Med; 1979 Feb; 8(6):444. PubMed ID: 317971
[No Abstract] [Full Text] [Related]
8. Prednimustine in adult acute myeloid leukaemia.
Brandt L; Könyves I
Cancer Chemother Pharmacol; 1979; 2(2):133-6. PubMed ID: 394873
[TBL] [Abstract][Full Text] [Related]
9. Prednimustine in elderly patients with multiple myeloma: a phase II study.
Tirelli U; Sorio R; Magri MD; Zagonel V; Vaccher E; Carbone A; Trovò M; Grigoletto E
Cancer Treat Rep; 1986 Apr; 70(4):537-8. PubMed ID: 3698051
[No Abstract] [Full Text] [Related]
10. Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemia.
Juul K; Sørensen P; Pedersen-Bjergaard J; Jensen MK
Scand J Haematol; 1979 Nov; 23(5):388-92. PubMed ID: 396664
[TBL] [Abstract][Full Text] [Related]
11. Prednimustine for prostate cancer therapy.
Slack NH; Murphy GP
Compr Ther; 1979 Sep; 5(9):54-7. PubMed ID: 487742
[No Abstract] [Full Text] [Related]
12. The pharmacokinetics of prednimustine and chlorambucil in the rat.
Newell DR; Shepherd CR; Harrap KR
Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268
[TBL] [Abstract][Full Text] [Related]
13. Prednimustine in advanced soft tissue sarcomas.
Karakousis CP; Didolkar MS; Ambrus JL; Holyoke ED
Cancer Treat Rep; 1982 Jan; 66(1):201-2. PubMed ID: 7053259
[No Abstract] [Full Text] [Related]
14. Prednimustine in advanced malignant melanoma: a phase II study.
Pedersen L; Løber J; Dalmark M; Mouridsen HT
Cancer Treat Rep; 1987 Dec; 71(12):1315-6. PubMed ID: 3690549
[No Abstract] [Full Text] [Related]
15. A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.
Gandara DR; Ries CA; Schiff SA; George CB; Lewis JP; Koretz MM; Carter SK
Cancer Chemother Pharmacol; 1982; 9(1):10-2. PubMed ID: 7139848
[TBL] [Abstract][Full Text] [Related]
16. [A phase II study of prednimustine in advanced ovarian cancer].
Grundsell H; Johnsson JE; Tropé C
Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
[No Abstract] [Full Text] [Related]
17. [Angio-immunoblastic lymphadenopathy].
Struyf NJ; Verhelst JA; Convens CG; Beelaerts WJ; Mathijs RJ; Mahler C
Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1516-8. PubMed ID: 8366940
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung.
Jensen HS; Hansen HH; Dombernowsky P
Cancer Chemother Pharmacol; 1980; 4(4):259-61. PubMed ID: 6254684
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
Rankin EM; Harvey C; Knight RK; Rubens RD
Cancer Treat Rep; 1987 Nov; 71(11):1107-8. PubMed ID: 3119205
[No Abstract] [Full Text] [Related]
20. Improved response to chemotherapy after interferon alpha-2b in angioimmunoblastic lymphadenopathy (AILD).
Hast R; Gustafsson B
Eur J Haematol; 1991 Jan; 46(1):51-2. PubMed ID: 1988308
[No Abstract] [Full Text] [Related]
[Next] [New Search]